Xiao-kun Zhang
South Xiangan Road
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Cdk1-phosphorylated Nur77 accumulates at the centrosome during mitosis to regulate the Cep192-PLK1 signaling axis.
Journal: Cell death & disease
Published: November 20, 2025
Disrupting the Formation of YAP Condensates Promotes the Activation of AMPKα to Inhibit the Progression of Primary Liver Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 10, 2025
RXRα modulates hepatic stellate cell activation and liver fibrosis by targeting CaMKKβ-AMPKα axis.
Journal: Acta pharmaceutica Sinica. B
Published: July 23, 2024
Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells.
Journal: European journal of medicinal chemistry
Published: May 23, 2024
ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia.
Journal: The Journal of biological chemistry
Published: March 14, 2024
Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion.
Journal: Cell reports
Published: March 28, 2023
Nur77 Serves as a Potential Prognostic Biomarker That Correlates with Immune Infiltration and May Act as a Good Target for Prostate adenocarcinoma.
Journal: Molecules (Basel, Switzerland)
Published: December 02, 2022
Nuclear receptor RXRα binds the precursor of miR-103 to inhibit its maturation.
Journal: BMC biology
Published: September 18, 2022
Disruption of the glucagon receptor increases glucagon expression beyond α-cell hyperplasia in zebrafish.
Journal: The Journal of biological chemistry
Published: April 27, 2022
The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 08, 2022
Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2.
Journal: Biochemical and biophysical research communications
Published: December 09, 2021
Last Updated: 09/26/2026